Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care Imaging is committed to providing outstanding care, utilizing state-of-the-art technology, and offering the subspecialty expertise of Stanford's world-renowned Department of Radiology. Our team of medical professionals conduct more than a quarter of a million studies each year, maintaining the highest standards of clinical excellence provided in a compassionate, caring environment.
Care and Treatment
Comprehensive breast imaging services include:
Digital Mammography—screening and diagnostic
Breast Ultrasound and Ultrasound-Guided Core-Needle and Stereotactic Biopsy
Consolidated imaging workstations for mammograms, ultrasounds, and magnetic resonance images in one room, allowing doctors to directly compare images from multiple sources
Breast MRI and MRI-guided interventions
PET-CT—used in the initial staging or re-staging of cancer and in its response to treatment
Tomosynthesis uses low dose x-rays to take mammogram images of the breast, and shows only a few layers of the breast at a time. Preliminary studies show higher cancer detection and lower false positives than full-field digital mammography (FFDM).
A procedure which uses ultrasound images to locate suspicious imaging findings, usually a breast mass. Small tissue samples are then removed using a fine needle to remove cells or a hollow needle (called a core biopsy.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referring Physicians.
What you need to know about patients with Medicare Part B and Advanced Diagnostic Imaging, effective January 1, 2022.
The Protecting Access to Medicare Act (PAMA) of 2014, established the Appropriate Use Criteria (AUC) program to increase use of AUC for advanced diagnostic imaging services (CT, MRI, PET, Nuclear Medicine) for Medicare Part B recipients.
Effective January 1st, 2022 providers must consult Appropriate Use Criteria (AUC) through a qualified Clinical Decision Support Mechanism (qCDSM) when ordering advanced diagnostic imaging services.
The purpose is to enable providers to order the most appropriate tests for patients while minimizing unnecessary radiation, intravenous contrast exposure, and potential risks of invasive procedures.
PRISM - Send and manage radiology orders online. Portal to include Medicare (CMS) mandate support features, such as:
*Clinical Decision Support Mechanism (qCDSM) when ordering advanced diagnostic imaging services.
*Advance Beneficiary Notice (ABN) - notification that services are likely not covered by Medicare.